Warner Pharmaceuticals announced that the company received the “Notice of Termination of Application for Drug Registration” approved and issued by the State Drug Administration and agreed to withdraw the registration application for the simethicone emulsion. This drug is mainly used to treat symptoms of discomfort caused by excessive gas accumulation in the gastrointestinal tract, such as bloating. The company submitted a marketing license application for this product to the State Drug Administration in January 2025 and was accepted, then decided to voluntarily withdraw the drug registration application. The voluntary withdrawal and termination of the drug registration application will not have a significant impact on the company's current and future production, operation and performance.

Warner Pharmaceuticals announced that the company received the “Notice of Termination of Application for Drug Registration” approved and issued by the State Drug Administration and agreed to withdraw the registration application for the simethicone emulsion. This drug is mainly used to treat symptoms of discomfort caused by excessive gas accumulation in the gastrointestinal tract, such as bloating. The company submitted a marketing license application for this product to the State Drug Administration in January 2025 and was accepted, then decided to voluntarily withdraw the drug registration application. The voluntary withdrawal and termination of the drug registration application will not have a significant impact on the company's current and future production, operation and performance.